Patent Application
20180338492
The present invention relates to improved biocide compositions in an aqueous solution based on magnesium fluoride which are suitable for a broad range of applications including the provision of antimicrobial activity on living tissue/skin, such as medical antiseptics, the provision of antimicrobial activity on other surfaces, such as general disinfectants in medical and non-medical fields, and/or the provision of antimicrobial activity or prevention of microbial activity, in particular fungal activity, in non-living objects, such as in additives to construction materials and paints or in a crop protection product.
Generally, it is desired to have fast acting and persistent antiseptics and disinfectants. It is further desired that crop protection products have a persistent antimicrobial activity.
Antiseptics or disinfectants are usually considered as “fast acting” if they achieve a significant reduction of the number of target micro-organisms in a time period of less than minutes following application of the antiseptic.
The term “persistence” relates to the ability of the antiseptic to maintain its antimicrobial activity once it is applied and is connected with the retention of or binding of the agent on the respective surface, e.g. the stratum corneum of the skin, after partial evaporation and after rinsing. The persistence can be measured by the time required for the microflora to be restored to the baseline before the application.
Currently, there are several very fast acting antiseptics, effective within 20 seconds against pathogenic microorganisms, commercially available. Most of these antiseptics are based on alcohols, iodine solutions or chlorides. However, all the conventional fast acting antiseptics cannot prevent fast repopulation of the treated surface, such as skin. In particular in the latter case this effect is at last partially due to the fact that the natural body protection (fatty acids, presence of balanced salts, regulated pH etc.) against microbial invasions has also been destroyed.
Furthermore, WO 2013/001433 A1 discloses an antibiofilm coating containing fluoride salt nanoparticles based on magnesium fluoride. The coating of WO 2013/001433 A1 is in particular intended to be applied to the surface of devices, e.g. biomedical devices and implants. With other words, WO 2013/001433 A1 discloses a very limited use of magnesium fluoride in an immobilized form as coatings.
In view of this prior art, the object underlying the present invention is to provide further improved and optimized specific biocide compositions based on magnesium fluoride which are essentially non-toxic, show an excellent antimicrobial performance, long-term stability, and are advantageously applicable for a broad range of medical and non-medical applications.
This object is achieved according to the present invention by the composition of claims 1. More specific and preferred embodiments and aspects of the invention are the subject of further claims.
The present invention provides a biocide composition in an aqueous solution according to claim 1 comprising at least the following components:
Advantageously, the aqueous solution comprising MgF2 has a pH less than 5.
Additionally to magnesium fluoride, the biocide composition of the present invention may further contain calcium fluoride as a component a).
The salicylic acid ester of component b) may be any ester suitable, in particular any ester which is water soluble and, in particular for medical applications, non-toxic and pharmacologically/physiologically acceptable in the concentrations used. Preferably, said ester is salicylic acid acetate (acetylsalicylic acid) or another ester of the hydroxyl group of salicylic acid with a lower alkyl carboxylic acid such as a C3-17 carboxylic acid, more specifically a C3-10 carboxylic acid.
The organic acid of component c) may be principally any carboxylic acid having antimicrobial activity which is non-toxic in the required concentration ranges.
Preferably the organic acid is selected from the group comprising or consisting of cinnamic acid, rosmarinic acid, vanillic acid, ascorbic acid, abscisic acid, mandelic acid, mevalonic acid, aspartic acid, salicylic acid, fumaric acid, isocitric acid, gallic acid, quinic acid, boswellic acid, carnosic acid, chlorogene acid, caffeic acid, other hydroxycarboxylic acids. A salt or ester of one or more of these compounds may be used as well.
Cinnamic acid represents a preferred component of the claimed composition. However, it is possible to substitute this compound by one or more of rosmarinic acid, vanillic acid, ascorbic acid, abscisic acid, mandelic acid, mevalonic acid, aspartic acid, salicylic acid, fumaric acid, isocitric acid, gallic acid or thymol or to combine cinnamic acid with one or more of these alternative compounds.
Also, a quinic acid, in particular D-(−)-quinic acid, represents a preferred component of the claimed composition. However, it is possible to substitute this compound by one or more of boswellic acid, carnosic acid, chlorogene acid, caffeic acid or to combine quinic acid with one or more of these alternative compounds.
The cationic polymer of component d) may be principally any cationic polymer having antimicrobial activity which is non-toxic for humans in the required concentration ranges for the respective applications. Preferably the cationic polymer is selected from the group comprising or consisting of a poly(alkylene)guanidin or -biguanidin, octenidin. Specific non-cationic polymers with antimicrobial activity such as polyethylene glycol may also be a component of the inventive compositions. Furthermore, it is assumed that the cationic group of the cationic polymer is advantageously less reactive with regard to the organic acids of the claimed composition.
Poly(alkylene)guanidines or -biguanidines can be prepared via the polycondensation of guanidinium salts, e.g. guanidinium hydrochloride, or, for biguanidines, sodium dicyanamide, with aliphatic diamines of a desired chain length (number of carbon atoms and methylene units in the molecule) by methods known in the art. The resulting polymers may by homopolymers or copolymers (if more than one diamine participates in said polycondensation).
More specifically, the cationic polymer is a poly(alkylene)guanidin or -biguanidin having a molecular weight in the range from 800 to 10,000, preferably 1,000 to 4,000 Dalton.
In a specific embodiment, the poly(alkylene)guanidines or poly(alkylene)biguanidines may have, e.g., an alkyl chain length of the monomer(s) in the range from C2-C14.
More specifically, the poly(alkylene)guanidine may be selected from the group comprising a poly(tetramethylen)guanidine, poly(hexa-methylen)guanidine (PHMG), a poly(octamethylen)guanidine, poly(decamethylen)guanidine, poly(dodecamethylen)guanidine or mixtures thereof.
In especially preferred embodiments, the cationic polymer is a poly(hexamethylen)guanidin (PHMG) or poly(hexamethylen)biguanidin (PHMB), in particular a lower PHMG or PMG having a molecular weight in the range as indicated above.
It is assumed that the surprisingly good results of the claimed composition is because the cationic polymer supports in particular the antimicrobial performance of magnesium fluoride (MgF2). For example, PHMG is known as having a destructive impact on the membrane function of bacterial cells.
The natural sea salt or synthetic equivalent thereof may be any salt composition which provides the desired benefits. Typically, these salts have an electrolytic composition which promotes the constructive metabolism of the skin. Preferably, the sea salt is salt from the Dead Sea or a synthetic equivalent (having the same major components) thereof.
Preferably, the cationic tenside is selected from the group comprising or consisting of benzalkonium chloride, distearyldimethylammonium chloride, esterquat, cetrimonium bromide, cetylpyridinium chloride or any possible mixture thereof. The usage of the cationic tenside has proven to have a synergistic effect with magnesium fluoride (MgF2) towards a notably fast-acting antimicrobial, in particular virucide, activity. Advantageously, the cationic tenside is used for providing a fast-acting disinfectant. It is assumed that the surprisingly good results of the claimed composition is based on the surface-active properties of the cationic tenside supporting in particular the performance of magnesium fluoride (MgF2). Furthermore, it is assumed that the cationic group of the cationic tenside is advantageously less reactive with regard to the organic acids of the claimed composition.
More preferably one of the following salts KCl, MgCl2, MgSO4, NaCl, NaF is used in combination with the cationic tenside in order to improve the antimicrobial activity, in particular the virucide activity against unveiled viruses.
Optionally, the claimed composition may also comprise alginate compounds and a rheological agent, such as xanthan gum. These additives are preferably present in compositions which are used for wound care products, such as wound gels, wound dressings etc., or in cosmetic formulations.
The alginate may be present as calcium alginate or other alginate compounds known in the art. Short-chain alginates, preferably comprising 180 to 500 saccharide units, such as 150 to 300 units or 150 to 200 units, are preferred. Alginate supports healing processes i.a. by promoting the constructive metabolism of the skin.
It was especially surprising that the combination of alginate and (sea) salt improves the performance of the claimed composition with respect to its skin regenerating properties in a synergistic manner.
Rheological agents such as xanthan gum are used to adjust the viscosity and consistency of the respective composition as desired. Xanthan gum is a stable and neutral thickener in the acidic range. The skilled artisan will recognize that other agents with the same essential properties could be used as well.
The concentrations of the various compounds in the claimed biocide compositions may vary considerably depending from the respective specific application and the presence of other specific components.
Typically, component a) is present in a range from 5 ppm to 45.000 ppm, preferably from 10 ppm to 35.000 ppm,
component b) is present in a range from 5 ppm to 80.000 ppm, preferably from 500 ppm to 60.000 ppm,
component c) is present in a range from 5 ppm to 80.000 ppm, preferably from 10 ppm to 60.000 ppm,
component d) is present in a range from 5 ppm to 50.000 ppm, preferably from 50 ppm to 30.000 ppm,
component e) is present in a range from 745.000 ppm to 999.980 ppm, preferably from 868.000 ppm to 999.000 ppm, and optionally
component f) is present in a range from 5 ppm to 30.000 ppm, preferably from 500 ppm to 3000 ppm and/or
component g) is present in a range from 500 ppm to 15.000 ppm, preferably from 1000 ppm to 8000 ppm.
Suitable general ranges for a number of essential or preferred specific components are compiled in the following Table 1.
Preferred ranges for a number of essential or preferred components which are especially suited for an antiseptic or “physiologic” disinfectant, i.e. intended for contacting living tissue/skin, are compiled in the following Table 2.
An exemplary biocide composition which is essentially suited for an antiseptic or physiologic disinfectant as define above comprises or consists of the following components:
Preferred ranges for a number or essential or preferred components which are especially suited for a (non-physiologic) disinfectant for surface treatment of other surfaces than skin or living tissue are compiled in the following Table 3.
An exemplary biocide composition which is especially suited for a non-physiologic disinfectant for surface treatment comprises or consists of the following components:
Preferred ranges for a number of essential or preferred components which are especially suited for a medical formulation for antiseptic wound care or the treatment of diseases caused by pathogens (such as viruses, bacteria, fungi) are compiled in the following Table 4.
Preferred ranges for a number of essential or preferred components which are especially suited for additives to construction materials and paints are compiled in the following Table 5.
An exemplary biocide composition which is especially suited for additive for construction materials and paints comprises or consists of the following components:
An exemplary biocide composition which is especially suited for additive for a medical formulation for antiseptic wound care or the treatment of diseases caused by pathogens (such as viruses, bacteria fungi) comprises or consists of the following components:
This composition or a similar composition may also be used in cosmetic formulations, in particular skin care or hair care products.
The compositions of the present invention, in particular those wherein component d) is a cationic polymer, preferably a poly(alkylene)-guanidine or -biguanidine or octenidin, more preferred a poly(alkylene)guanidine, are also suitable as a crop protecting agent or product.
Preferred ranges for a number of essential or preferred components which are especially suited for a crop protection product are compiled in the following Table 6.
Preferred ranges for a number of essential or preferred components which are especially suited for a fast-acting disinfectant are compiled in the following Table 7.
It has been proven that, advantageously, alginate improves the long-time activity of the fast-acting disinfectant.
Advantageously, the biocide compositions of the present invention are free of ethanol, propanol, hypochlorite or hydrogen peroxide.
The claimed aqueous biocide compositions and gels are fast acting, persistent and long term-stable, such as for a time period of at least 3 years.
As already mentioned above, the biocide compositions of the invention are suitable for a broad range of applications including the provision of antimicrobial activity on living tissue/skin, such as antiseptic medical formulations or physiologic disinfectants, and/or the provision of antimicrobial activity or prevention of microbial activity, in particular fungal activity, in non-living objects, such as additives to construction materials and paints.
Consequently more specific aspects of the invention relate to the use of such compositions as a physiologic disinfectant as a general non-physiologic surface disinfectant, as an additive for construction materials and paints, as a crop protecting agent, as an antiseptic medical formulation for the treatment of diseases caused by pathogens such as bacteria, fungi and viruses, and to the use in an antiseptic wound gel or an antiseptic wound dressing. A still further aspect of the invention relates to the use of such compositions in an antiseptic cosmetic formulation.
Further, closely related aspects of the invention relate to a disinfectant comprising or consisting of such compositions for the treatment of physiologic surfaces, i.e. surfaces which comprise living tissue or skin, or for non-physiologic surfaces, i.e. surfaces which are not comprising living tissue or skin, to an additive, in particular antimycotic additive, for construction materials and paints, which additive comprises or consists of such compositions, to a crop protecting product, to an antiseptic wound gel comprising or consisting of such composition, to an antiseptic cosmetic formulation, in particular a skin care or hair care product, which comprises or consists of such a composition, and to an antiseptic medical formulation for the treatment of diseases caused by pathogens such as bacteria, fungi and viruses, comprising or consisting of such a composition.
A still further aspect of the invention relates to a method for treating diseases, in particular diseases which affect the skin, caused by pathogens such as bacteria, fungi and viruses which method comprises the topical application of an antiseptic formulation comprising or consisting of such a composition onto skin or tissue of a subject suffering from such a disease.
The composition of the present invention may be used in variety of forms, as appropriate for the respective application. The may be used as an aqueous solution or suspension, including a composition suitable for application as a spray, as a gel or cream, etc. They may be used as such or combined with other active principles or carrier materials (e.g. in a wound-dressing).
The present invention is further illustrated by the following non-limiting Examples.
A biocide composition for use as a physiologic disinfectant or antiseptic was prepared by mixing the following components in the indicated ratios
and tested with respect to its performance.
A biocide composition for use as a non-physiologic surface disinfectant was prepared by mixing the following components in the indicated ratios
and tested with respect to its performance.
A biocide composition for use as an antiseptic medical formulation for the treatment of diseases caused by pathogens (bacteria, fungi and viruses) was prepared by mixing the following components in the indicated ratios
and tested with respect to its performance.
A biocide composition for use as an antimycotic additive to construction materials and paints was prepared by mixing the following components in the indicated ratios
added to paint in a desired concentration and tested with respect to its performance.
A biocide composition for use in an antiseptic wound gel was prepared by mixing the following components in the indicated ratios
and tested with respect to its performance.
A biocide composition for use as a crop protection product was prepared by mixing the following components in the indicated ratios
A biocide composition for use as a fast-acting disinfectant was prepared by mixing the following components in the indicated ratios
| Number | Date | Country | Kind |
|---|---|---|---|
| 01574/15 | Oct 2015 | CH | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2016/001784 | 10/26/2016 | WO | 00 |
